Trial Profile
Phase II Study of Panitumumab with Fluorouracil in Patients With KRAS Wild-type Metastatic Colorectal Cancer(PF Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Panitumumab (Primary) ; Capecitabine; Folinic acid; Gimeracil/oteracil/tegafur; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Aug 2018 Status changed from active, no longer recruiting to completed.
- 02 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Jun 2012 Additional lead investigator (Hideyuki Mishima) identified as reported by University Hospital Medical Information Network - Japan record.